Launching Atropine Sulfate Injection, USP, 1 mg/10 mL (0.1 mg/mL), in plastic pre-filled syringe

Our Business Model

Medefil is growing as a fully integrated specialty pharmaceutical company. At Medefil our goal is to develop and manufacture injectable products where quality and supply reliability are crucial, and safety and ease-of-use are of utmost importance.

We are focused on establishing an organization with comprehensive infrastructure for injectable product development, state-of-the-art manufacturing capabilities and a streamlined process for execution that will help address critical issues and unmet needs in the pharmaceutical injectable space.

Critical Injectables

Injectable products with shortage and supply issues

Complex Injectables

Difficult to develop and manufacture injectable products

Product Enhancement

Enhancement of injectable products to create value at the point of care

Our Pipeline

Critical Injectables

Therapeutic AreaFDA FilingDelivery TechnologyHistory of Shortage
Critical CareANDASyringeYes
Critical CareANDAVialYes
PainANDAVialNo
Anti-InfectiveANDAVialNo
Critical CareANDASyringeNo
Anti-InjectiveANDALyoNo
Critical CareNDA VialYes
Critical CareANDAVialYes
Critical CareANDAVialYes
Critical CareANDAVialYes
Critical CareANDAVialYes
Critical CareANDAVialYes

 

Complex Injectables

Therapeutic AreaFDA FilingDelivery Technology
PainANDAPremix Bag
Critical CareANDASuspension
Anti-InfectiveANDAPremix Bag
Critical CareANDASuspension

Reach Out

We’re eager to meet your needs and deliver solutions